MedTrace Logo

Evidence Generation Related to Stunting Prevention in Balochistan

NCT03689218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2180

Last updated 2021-07-23

No results posted yet for this study

Summary

The World Food Programme (WFP) has signed MoU with Planning and Development Department of Balochistan in collaboration with Nutrition Cell and National Programme for Family Planning and Primary Health Care, Balochistan for the prevention of stunting. The project will utilize the window of opportunity (1000 days from conception to 2 years) for addressing stunting in children under-two years. Therefore project will recruit pregnant women during first trimester and newborns who delivered from recruited pregnant women will be followed until the age of 2 years. Children 6-12 months of age will be enrolled and followed until the age of two years. The interventions included nutritional supplements during pregnancy, lactation and for children during 6-24 months of age. The project will be implemented in Lady Health Workers (LHWs) covered areas of districts Pishin and Quetta, Balochistan.

Conditions

Interventions

DIETARY_SUPPLEMENT

Maamta (Nutritious Food Supplement)

Pregnant women will receive 30 sachets of Maamta during pregnancy and first six months of lactation.

DIETARY_SUPPLEMENT

Wawamum (Lipid-Based Nutrient Supplement)

Children 6-24 months will receive 30 sachets of Wawamum every month during the study.

Sponsors & Collaborators

  • Trust for Vaccines & Immunization (TVI)

    collaborator UNKNOWN

  • Department of Health, Government of Balochistan

    collaborator UNKNOWN

  • World Food Program (WFP)

    collaborator UNKNOWN

  • Nutrition Cell, Government of Balochistan

    collaborator UNKNOWN

  • Youth Organization, Balochistan

    collaborator UNKNOWN

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Sajid B Soofi, FCPS, MBBS · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03689218 on ClinicalTrials.gov